Neurotoxicity Syndromes
Information
- Disease name
- Neurotoxicity Syndromes
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02481336 | Active, not recruiting | To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity | March 2015 | December 31, 2025 | |
| NCT04150913 | Active, not recruiting | Phase 2 | A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity | October 5, 2020 | October 31, 2025 |
| NCT00176553 | Terminated | N/A | A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity | March 2003 | May 2007 |
| NCT03954106 | Terminated | Phase 2 | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity | October 4, 2019 | September 30, 2020 |
| NCT00389259 | Withdrawn | N/A | Scopolamine Treatment for Patients With Organophosphate Poisoning | October 2007 | December 2009 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020258